Description
The anti-DLL-3 chimeric antigen receptor (CAR) THP1 cell line is a stable cell line developed using anti-DLL-3 CAR lentivirus transfection. This transfected CAR lentiviral vector is constructed to express a scfv of anti-DLL-3 antibody (Rovalpituzumab) linked to CD147 signaling domains.The anti-DLL-3 CAR engineered THP1 cells can be used to be differentiated into macrophage cells for in vitro or in vivo phagocytosis studies. This CAR-THP1 cell line product can be used for the researches of Lung cancer